KIDNEY (RENAL CELL) CANCER

Refine Results:
All Categories Epidemiology and Etiology (146) Prevention and Screening (45) Diagnosis and Staging (250) Treatment (486) Supportive Oncology (30)

CME

Fred Visit 1: A 67-year-old Patient Presenting With a Renal Mass
An interactive CME program powered by Real CME
OncologySTAT CME
Bill Visit 1: A 70-year-old Patient Presenting With Metastatic Renal Cell Carcinoma
An interactive CME program powered by Real CME
OncologySTAT CME

News

Inlyta Approval Expands Pfizer Kidney Cancer Options, But With Unique Safety Profile
The Pink Sheet Daily, 2012 Jan 27, S Haley
FDA Approves Axitinib for Advanced Kidney Cancer
Elsevier Global Medical News, 2012 Jan 27, E Mechcatie
FDA Panel Backs Axitinib for Advanced Kidney Cancer
Elsevier Global Medical News, 2011 Dec 7, E Mechcatie
Protein Kinase Inhibitors Spur Keratoacanthomalike Growths
Elsevier Global Medical News, 2011 Nov 30, B Bates
Axitinib Extends Progression-Free Survival in Kidney Cancer Trial
Elsevier Global Medical News, 2011 Jun 13, R Hyer
More News ›

Journal Scans: Research

Complete Remission With Tyrosine Kinase Inhibitors in Renal Cell Carcinoma
J Clin Oncol, 2012 Jan 9, L Albiges, et al
Natural History of Untreated Renal Cell Carcinoma With Venous Tumor
Urol Oncol, 2012 Jan 9, AC Reese, et al
Free Journal Content
Multicenter Phase II Study of Sunitinib in Patients With Non-Clear Cell Renal Cell Carcinoma
Ann Oncol, 2012 Jan 6, JL Lee, et al
Severe Clinical Toxicities Are Correlated With Survival in Patients With Advanced Renal Cell Carcinoma Treated With Sunitinib and Sorafenib
Br J Cancer, 2011 Dec 6, F Di Fiore, et al
Comparative Effectiveness of Axitinib Versus Sorafenib in Advanced Renal Cell Carcinoma (AXIS): A Randomised Phase 3 Trial
Lancet, 2011 Dec 3, BI Rini, et al
More Journal Scans: Research ›

Journal Scans: Review

The Risk of Skin Rash and Stomatitis With the Mammalian Target of Rapamycin Inhibitor Temsirolimus: A Systematic Review of the Literature and Meta-Analysis
Eur J Cancer, 2011 Dec 29, C Gomez-Fernandez, et al
Free Journal Content
Consolidative Surgery After Targeted Therapy for Renal Cell Carcinoma
Urol Oncol, 2011 Dec 6, AA Thomas, et al
Free Journal Content
Radiopharmaceuticals: When and How to Use Them to Treat Metastatic Bone Pain
J Support Oncol, 2011 Nov 1, FM Paes, et al
Free Journal Content
Small Cell Carcinoma of the Upper Urinary Tract (UUT-SCC): Report of a Rare Entity and Systematic Review of the Literature
Cancer Treat Rev, 2011 Aug 1, A Ouzzane, et al
Management of Treatment-Related Toxicity with Targeted Therapies for Renal Cell Carcinoma: Evidence-Based Practice and Best Practices
Hematol Oncol Clin North Am, 2011 Aug 1, L Appleby, et al
More Journal Scans: Review ›

Expert Opinion

Targeted Therapy for Patients With Renal Cell Carcinoma
Lancet Oncol, 2011 Oct 18, BI Rini
Free Journal Content
Approvals for Bevacizumab and Pazopanib Add Options for Advanced Kidney Cancer
Top Stories of 2009, 2010 Jan 1
First-Line Therapy in Advanced RCC: Interview With Robert Motzer, MD
OncologySTAT Editorial Team, 2009 Aug 31, Interview by L Scott Zoeller
Highlighting Noteworthy Clinical Presentations at the 2009 NCCN Conference
OncologySTAT Editorial Team, 2009 Mar 5, L Scott-Zoeller
Exclusive Interview With Drs. Lee Schwartzberg and David Henry
Linda Bosserman for the OncologySTAT Editorial Team, 2008 Feb 12

Chemotherapy Regimens

Temsirolimus (Kidney)
The Elsevier Guide to Oncology Drugs & Regimens (2008 edition)
Sunitinib (Kidney)
The Elsevier Guide to Oncology Drugs & Regimens (2008 edition)
Sorafenib (Kidney)
The Elsevier Guide to Oncology Drugs & Regimens (2008 edition)
Interleukin-2 (Kidney)
The Elsevier Guide to Oncology Drugs & Regimens (2008 edition)
Interferon alfa-2a, interleukin-2 (Kidney)
The Elsevier Guide to Oncology Drugs & Regimens (2008 edition)
More Chemotherapy Regimens ›

Conference Coverage

2010 Genitourinary Cancers Symposium
March 5-7 2010 San Francisco, et al

Videos

Axitinib Showed Two-Month Advantage To Sorafenib
Elsevier Global Medical News, 2011 Jun 6
Famine to Feast: Many New RCC Options
Community Oncology Conference , 2008 Feb 1, Linda Bosserman MD

Summary of Key Points

Kidney and Ureter
Abeloff's Clinical Oncology, 4th ed. 2008

Updated Key Points: Kidney (Renal Cell) Cancer

Summary information about kidney (renal cell) cancer has been completely revised with updated information from Abeloff's Clinical Oncology, 4th ed.
Read more ›

Cancer Policy Forum

Behind-the headlines perspectives on health care reform, cancer-related drug legislation, and other topics likely to have a major impact on oncology practice.
Read articles ›

Cancer Type

  • Bladder
  • Bone
  • Breast
  • Breast (ER-Positive)
  • CNS/Brain
  • Colon and Rectum
  • Endocrine System
  • Esophagus
  • GYN (Non-Ovary)
  • GYN (Ovary)
  • Head and Neck
  • Hodgkin's Lymphoma
  • Kidney (Renal Cell)
  • Leukemia
  • Liver and Bile Duct
  • Lung
  • Multiple Myeloma
  • Myelodysplastic Syndrome
  • Myeloproliferative Diseases
  • Non-Hodgkin's Lymphoma
  • Pancreas
  • Pediatric Cancers
  • Prostate
  • Rare Cancers
  • Skin
  • Soft-Tissue Sarcoma
  • Stomach
  • Testicle
    • Forgot your password?
    Not a member? Free registration